Published in Eur J Immunol on August 01, 1975
Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med (1979) 12.22
Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG. J Exp Med (1977) 9.57
Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc Natl Acad Sci U S A (1979) 4.98
Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. A comparison. J Exp Med (1980) 3.03
Lymphocyte receptors. II. Receptors for rabbit IgM on human T lymphocytes. Immunology (1976) 2.06
Colony formation by human T lymphocytes in agar medium. Clin Exp Immunol (1977) 2.03
Identity of the elusive IgM Fc receptor (FcmuR) in humans. J Exp Med (2009) 1.72
Subpopulations of human T lymphocytes. I. Studies in immunodeficient patients. Clin Exp Immunol (1977) 1.69
Analysis by a plaque assay of IgG- or IgM- dependent cytolytic lymphocytes in human blood. J Exp Med (1976) 1.69
Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. I. A hybridoma secreting antibody against a marker specific for human B lymphocytes. Clin Exp Immunol (1980) 1.66
Molecular cloning of two CD7 (T-cell leukemia antigen) cDNAs by a COS cell expression system. EMBO J (1987) 1.57
B-lymphocytes activation by the Fc region of IgG. J Exp Med (1977) 1.51
The differential effect of in vivo hydrocortisone on the kinetics of subpopulations of human peripheral blood thymus-derived lymphocytes. J Clin Invest (1978) 1.49
Specificity of fc receptors for IgG2a, IgG1/IgG2b, and IgE on rat macrophages. J Exp Med (1981) 1.40
Physiology of IgD. IV. Enhancement of antibody production in mice bearing IgD-secreting plasmacytomas. J Exp Med (1984) 1.37
Unusual phenotype and function of an expanded subpopulation of T cells in patients with haemopoietic disorders. Clin Exp Immunol (1981) 1.35
A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias. Am J Pathol (1978) 1.33
Fc-receptors, Ia-antigens, and immunoglobulin on normal and activated mouse T lymphocytes. J Exp Med (1975) 1.32
Malignant lymphomas--a conceptual understanding of morphologic diversity. A review. Am J Pathol (1979) 1.30
Critical role of the IgM Fc receptor in IgM homeostasis, B-cell survival, and humoral immune responses. Proc Natl Acad Sci U S A (2012) 1.29
Specific adsorption of IgM antibody onto H-2-activated mouse T lymphocytes. J Exp Med (1976) 1.26
Increase of IgA specific helper T alpha cells in patients with IgA nephropathy. Clin Exp Immunol (1982) 1.18
Isotype-specific immunoregulation. IgA-binding factors produced by Fc alpha receptor-positive T cell hybridomas regulate IgA responses. J Exp Med (1985) 1.17
Phagocytic peripheral blood monocytes from rabbits and humans express membrane receptors specific for IgM molecules: evidence that incubation with neuraminidase exposes cryptic IgM (Fc) receptors. Clin Exp Immunol (1979) 1.17
Clinical findings and immunological abnormalities in Yu-Cheng patients. Environ Health Perspect (1985) 1.17
Studies of cell subpopulations mediating mitogen hyporesponsiveness in patients with Hodgkin's disease. J Clin Invest (1978) 1.16
Alteration in T lymphocyte subpopulations in inflammatory bowel disease. Clin Exp Immunol (1980) 1.13
T-cell regulation of human peripheral blood B-cells responsiveness. J Exp Med (1977) 1.11
Characteristics and function of Fc receptors on human lymphocytes. Immunology (1982) 1.09
The determination of numbers of T and B lymphocytes in the blood of children and adults by the direct immunofluorescence technique. Clin Exp Immunol (1977) 1.09
Receptors for IgA on a subpopulation of human B lymphocytes. Proc Natl Acad Sci U S A (1979) 1.08
Heterogeneity of locomotion in human T cell subsets. Proc Natl Acad Sci U S A (1978) 1.06
Immunological studies in typhoid fever. II. Cell-mediated immune responses and lymphocyte subpopulations in patients with typhoid fever. Clin Exp Immunol (1982) 1.00
Evidence that T colony formation is a property of T mu (helper) lymphocytes. Clin Exp Immunol (1980) 0.98
Fc receptors for IgG, IgM and IgE on human leukaemic lymphocytes. Clin Exp Immunol (1979) 0.97
Cellular immunity in pregnancy: subpopulations of T lymphocytes bearing Fc receptors for IgG and IgM in pregnant women. Clin Exp Immunol (1980) 0.96
T-chronic lymphocytic leukaemia presenting as primary hypogammaglobulinaemia--evidence of a proliferation of T-suppressor cells. Clin Exp Immunol (1982) 0.95
Differential sensitivity of lymphocyte subpopulations to suppression by low density lipoprotein inhibitor, an immunoregulatory human serum low density lipoprotein. J Clin Invest (1979) 0.95
Subpopulations of T lymphocytes in myasthenia gravis patients. Clin Exp Immunol (1979) 0.95
Isolation of various canine leucocytes and their characterization by surface marker analysis. Immunology (1978) 0.93
Lymphocytes binding C-reactive protein during acute rheumatic fever. J Clin Invest (1978) 0.92
Biochemical nature of an Fc mu receptor on human B-lineage cells. J Exp Med (1990) 0.92
Studies on the nature of EA binding by lymphocytes from rheumatoid arthritis patients. Clin Exp Immunol (1977) 0.91
Receptors for IgM on human lymphocytes. II. Mitogen-induced modulation of receptor expression. Clin Exp Immunol (1979) 0.91
Neuraminidase- and trypsin-induced exposure to membrane receptors for IgG and IgM molecules on human peripheral blood lymphocytes. Clin Exp Immunol (1977) 0.90
Evidence for the presence of a receptor for IgM on the pathological cells of Sézary's syndrome. Clin Exp Immunol (1978) 0.90
Fractionation of human T lymphocytes on wheat germ agglutinin-sepharose. J Exp Med (1976) 0.90
Immunologic diagnosis and monitoring of human acute leukemias: a review. Am J Pathol (1981) 0.90
Studies of T- and B-cell interactions in adult patients with combined immunodeficiency. J Clin Invest (1980) 0.90
Subpopulations of lymphocytes in human thymomas. Clin Exp Immunol (1979) 0.90
Receptors for IgM and IgM-antigen complexes on human T-lymphocytes reacting with specific anti-human-T-cell antiserum. Immunology (1977) 0.90
Differential promoter utilization by the c-myc gene in mitogen- and interleukin-2-stimulated human lymphocytes. Mol Cell Biol (1987) 0.89
Separation of human T lymphocyte subpopulations (Tmu, Tgamma) by density gradient electrophoresis. Proc Natl Acad Sci U S A (1979) 0.87
Lymphocyte receptors. I. Receptors for Fc of IgG and complement (C3b) on immunoglobulin-bearing, antigen-binding and antibody-secreting cells. Immunology (1976) 0.86
The in vitro culture characteristics and requirements for expression of receptors for IgM on human peripheral blood lymphocytes. Clin Exp Immunol (1980) 0.86
Receptors for IgM on human lymphocytes. III. Specificity of receptors. Clin Exp Immunol (1979) 0.86
Receptors for IgM: a feature of subpopulations of both T and B human lymphocytes. Clin Exp Immunol (1978) 0.85
Subpopulations of T lymphocytes and non-specific suppressor cell activity in patients with atopic dermatitis. Clin Exp Immunol (1981) 0.84
RNA content in human lymphocyte subpopulations. Proc Natl Acad Sci U S A (1978) 0.84
Identification of three FcR-positive T cell subsets (T gamma, T mu and T gamma mu) in the cerebrospinal fluid of multiple sclerosis patients. Clin Exp Immunol (1980) 0.84
T lymphocyte subpopulations and Ia-positive T cells in patients with immunodeficiency. Clin Exp Immunol (1980) 0.84
Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. III. A marker defining a subpopulation of lymphocytes which cuts across the normal T-B-null classification. Immunology (1980) 0.83
Generation of interleukin-2-dependent T cell lines from synovial fluids in rheumatoid arthritis. Clin Exp Immunol (1984) 0.83
Distribution and properties of Fc receptors for IgG on different leucocyte populations in man. Clin Exp Immunol (1981) 0.83
Studies on the structural and biological functions of the Cmu4 domains of IgM. Immunology (1978) 0.83
Study of some properties of the receptor for IgM on human lymphocytes. Clin Exp Immunol (1979) 0.81
Production of migration inhibition factor (MIF) by purified human T cell subpopulations. Clin Exp Immunol (1981) 0.81
Rosette formation with goat erythrocytes. A marker for human T lymphocytes. Clin Exp Immunol (1978) 0.81
Receptors for immunoglobulin isotype on T and B lymphocytes from untreated patients with chronic lymphocytic leukaemia. Clin Exp Immunol (1980) 0.80
Different divalent cation requirements for binding IgM complexes to lymphocytes and macrophages. J Exp Med (1980) 0.80
Imbalances in peripheral blood T-cell subpopulations in renal transplant patients. Clin Exp Immunol (1981) 0.80
Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency. Clin Exp Immunol (1981) 0.79
Binding of different ligands to IgM-Fc receptors of rat leucocytes. Immunology (1982) 0.79
Antigenic modulation of the cytophilic binding of guinea-pig IgG and IgM antibodies to homologous macrophages. Immunology (1979) 0.79
Immunosuppression and alterations of T-lymphocyte subpopulations after rubella vaccination. Infect Immun (1980) 0.79
Characterization of the receptor for IgM present on human B lymphocytes. Immunology (1979) 0.79
Modulation of Fc receptors on human peripheral blood lymphocytes by antisera against beta 2 microglobulin, Ia or immunoglobulin. Immunology (1979) 0.79
Infection of multiple T-cell subsets and changes in lymphocyte functions associated with Herpesvirus saimiri infection of owl monkeys. Infect Immun (1981) 0.79
Surface markers of lymphocytes in the snake, Spalerosophis diadema. I. Investigation of lymphocyte surface markers. Immunology (1980) 0.78
Cells and mediators which participate in immunoglobulin synthesis by human mononuclear cells. II. The mechanism of null cell participation in immunoglobulin synthesis and secretion by B cells. Clin Exp Immunol (1990) 0.78
Neuraminidase treatment of human T lymphocytes: effect on Fc receptor phenotype and function. Clin Exp Immunol (1980) 0.78
T-cell nature of leukaemic cells in a case of Sézary's syndrome with 'null-cell' features. J Clin Pathol (1979) 0.77
Lymphocyte antigens in systemic lupus erythematosus: studies with heterologous antisera. J Clin Invest (1980) 0.77
Generation of B suppressor cells by phytohaemagglutinin. Immunology (1986) 0.77
Immunoglobulin production after marrow transplantation. III. The functional heterogeneity of FC-IgG receptor positive and negative T cell subpopulations. Clin Exp Immunol (1982) 0.77
Antibody--antigen complex stimulated lysis of non-sensitized sheep red cells by human lymphocytes. I. Requirements for IgG complexes. Clin Exp Immunol (1979) 0.76
Lack of evidence for IgM-induced ADCC: studies with monoclonal and polyclonal antibodies. Immunology (1981) 0.76
Spontaneous mouse erythrocyte-rosette formation in chronic lymphocytic leukaemia. Clin Exp Immunol (1982) 0.75
Characterization of the Fc(IgG) receptor on the pluripotential leukaemia cell K-562. Clin Exp Immunol (1985) 0.75
Receptors for immunoglobulin and complement on sheep RBC-binding lymphocytes in newborn infants. Clin Exp Immunol (1978) 0.75
Study of human T and B lymphocytes with heterologous antisera. IV. Subpopulations in tonsil and adenoid cell suspensions. Immunology (1978) 0.75
Immunoregulatory T cells in the peripheral blood of patients with Bechterew's syndrome. Ann Rheum Dis (1982) 0.75
Selective blocking of T cell-mediated in vitro cytotoxicity to a xenogeneic tumour by anti-immunoglobulin sera. Clin Exp Immunol (1978) 0.75
Antiserums for immunofluorescent enumeration of human T lymphocytes utilizing fluoresceinated staphylococcal protein A. Am J Pathol (1978) 0.75
An IgM-producing immunocytoma induces large numbers of splenic T lymphocytes with Fc mu receptors. Immunology (1987) 0.75
The effect of the plant lectins phytohaemagglutinin and concanavalin A on human T cell populations bearing receptors for IgG and IgM. Clin Exp Immunol (1980) 0.75
Antibody-dependent cellular cytotoxicity mediated by subpopulations of human T lymphocytes: killing of human erythrocytes and autologous lymphoid cells. Immunology (1980) 0.75
Dexamethasone enhancement of the induction of cells bearing receptors for IgM in human peripheral blood lymphocyte culture. Clin Exp Immunol (1980) 0.75
Subpopulations of T lymphocytes in patients with ankylosing spondylitis. Ann Rheum Dis (1980) 0.75
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood (1999) 11.57
Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG. J Exp Med (1977) 9.57
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol (2001) 7.07
Subpopulations of human T cells identified by receptors for immunoglobulins and mitogen responsiveness. J Immunol (1976) 4.64
Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity. J Exp Med (1983) 4.47
Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol (1996) 4.24
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest (1998) 3.96
NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med (1998) 3.83
Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity (1995) 3.72
Receptors for IgG molecules on human lymphocytes forming spontaneous rosettes with sheep red cells. Eur J Immunol (1975) 3.26
Heterogeneity of tonsillar subepithelial B lymphocytes, the splenic marginal zone equivalents. J Immunol (2000) 3.13
Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med (1998) 3.09
Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med (1999) 3.08
Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. A comparison. J Exp Med (1980) 3.03
A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function. J Exp Med (1990) 2.93
Two subsets of human T lymphocytes expressing gamma/delta antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor. J Exp Med (1988) 2.86
Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med (1995) 2.75
p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J Exp Med (1997) 2.70
Morphological and histochemical analyses of two human T-cell subpopulations bearing receptors for IgM or IgG. J Exp Med (1978) 2.58
Fc-receptor heterogeneity of human suppressor T cells. J Immunol (1978) 2.37
NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med (1999) 2.17
Quantitative assessment of the pool size and subset distribution of cytolytic T lymphocytes within human resting or alloactivated peripheral blood T cell populations. J Exp Med (1983) 2.16
Specific lysis of allogeneic cells after activation of CD3- lymphocytes in mixed lymphocyte culture. J Exp Med (1988) 2.14
Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. Proc Natl Acad Sci U S A (1992) 2.08
Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: definition of five distinct NK-determined allospecificities in humans. J Exp Med (1992) 2.04
Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J Exp Med (1994) 1.98
Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis. Immunol Today (2000) 1.95
Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur J Immunol (2001) 1.93
Involvement of T44 molecules in an antigen-independent pathway of T cell activation. Analysis of the correlations to the T cell antigen-receptor complex. J Exp Med (1985) 1.92
Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol (1996) 1.90
Distribution of T cells bearing different forms of the T cell receptor gamma/delta in normal and pathological human tissues. J Immunol (1989) 1.89
Surface markers of cloned human T cells with various cytolytic activities. J Exp Med (1981) 1.87
Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells. Nature (1985) 1.85
Antigen recognition by human T cell receptor gamma-positive lymphocytes. Specific lysis of allogeneic cells after activation in mixed lymphocyte culture. J Exp Med (1988) 1.84
Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur J Immunol (1997) 1.84
NK cells at the interface between innate and adaptive immunity. Cell Death Differ (2007) 1.83
Human natural killer cells: origin, clonality, specificity, and receptors. Adv Immunol (1994) 1.83
Human T lymphocyte subpopulations: studies of the mechanism by which T cells bearing Fc receptors for IgG suppress T-dependent B cell differentiation induced by pokeweed mitogen. J Immunol (1979) 1.80
Active thymus derived suppressor lymphocytes in human cord blood. Nature (1977) 1.80
Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev (1997) 1.77
Imbalances in T cell subpopulations associated with immunodeficiency and autoimmune syndromes. Eur J Immunol (1977) 1.74
Loss of Fc receptors for IgG from human T lymphocytes exposed to IgG immune complexes. Nature (1978) 1.73
A monoclonal antibody specific for a common determinant of the human T cell receptor gamma/delta directly activates CD3+WT31- lymphocytes to express their functional program(s). J Exp Med (1988) 1.71
The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur J Immunol (1997) 1.69
Phenotypic characterization of human cytolytic T lymphocytes in mixed lymphocyte culture. J Exp Med (1981) 1.66
Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T-cell cross-priming. Nat Med (2001) 1.66
2B4 functions as a co-receptor in human NK cell activation. Eur J Immunol (2000) 1.65
Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients. J Immunol (2000) 1.64
Specific recognition of human CD3-CD16+ natural killer cells requires the expression of an autosomic recessive gene on target cells. J Exp Med (1990) 1.63
Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci U S A (1999) 1.53
Mutant EL-4 thymoma cells polyclonally activate murine and human B cells via direct cell interaction. J Immunol (1985) 1.53
The demonstration of acid alpha-naphthyl acetate esterase activity in human lymphocytes: usefulness as a T-cell marker. Cell Immunol (1978) 1.52
Two novel Italian CADASIL families from Central Italy with mutation CGC-TGC at codon 1006 in the exon 19 Notch3 gene. Neurol Sci (2006) 1.51
Transmembrane signalling via the T11-dependent pathway of human T cell activation. Evidence for the involvement of 1,2-diacylglycerol and inositol phosphates. Eur J Immunol (1987) 1.49
CD16 surface molecules regulate the cytolytic function of CD3CD16+ human natural killer cells. Int J Cancer (1989) 1.48
Selection and characterization of T-cell variants lacking molecules involved in T-cell activation (T3 T-cell receptor, T44, and T11): analysis of the functional relationship among different pathways of activation. Proc Natl Acad Sci U S A (1987) 1.47
The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity. Eur J Immunol (1999) 1.47
Identification of NKp80, a novel triggering molecule expressed by human NK cells. Eur J Immunol (2001) 1.46
Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers. J Infect Dis (1994) 1.46
Cyclosporin A in the treatment of juvenile chronic arthritis and childhood polymyositis-dermatomyositis. Results of a preliminary study. Clin Exp Rheumatol (1993) 1.43
Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur J Immunol (1999) 1.42
Characterization of human T-cell subpopulations as defined by specific receptors for immunoglobulins. Contemp Top Immunobiol (1978) 1.42
Immunology in Italy. Immunol Today (1988) 1.40
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1. Cell Death Dis (2012) 1.40
Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci U S A (1996) 1.39
Ultrastructure and cytochemistry of human peripheral blood lymphocytes. Similarities between the cells of the third population and TG lymphocytes. Eur J Immunol (1980) 1.38
Selection and characterization of monoclonal antibodies to the idiotype-like structure of an interleukin-2-producing human leukemia T-cell line. Int J Cancer (1985) 1.38
Receptors for IgM on certain human B lymphocytes. J Immunol (1977) 1.37